Sensitivity of pre-T cells to natural thymocytotoxic autoantibodies developed in New Zealand Black mice. 1982

Y Imai, and T Osawa

The effect of affinity purified natural thymocytotoxic autoantibodies from New Zealand Black (NZB) mice (NTA-1 and NTA-2) against pre-T cells was studied. Pre-treatment of spleen cells from nu/nu mice or bone marrow cells from DBA/2 mice with NTA-1 and complement (C) or with NTA-2 and C markedly inhibited the induction of T cell markers with a thymic extract in vitro. The effect of NTA-2 and C was abolished by absorption of NTA-2 with neuraminidase treated thymocytes, whereas its effect was not abolished by absorption with intact thymocytes. The effect of NTA-1 and C was abolished by absorption of NTA-1 with either neuraminidase treated thymocytes or intact thymocytes. The effect of NTA-2 was inhibited by lactose whereas the effect of NTA-1 was not. These results suggest that NTA-2 specifically recognizes the cell surface characteristics of pre-T cells and blocks the differentiation pathway of T cells.

UI MeSH Term Description Entries
D008814 Mice, Inbred NZB An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS. Mice, NZB,Mouse, Inbred NZB,Mouse, NZB,Inbred NZB Mice,Inbred NZB Mouse,NZB Mice,NZB Mice, Inbred,NZB Mouse,NZB Mouse, Inbred
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006241 Haptens Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. Hapten,Contact-Sensitizing Agents,Agents, Contact-Sensitizing,Contact Sensitizing Agents
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

Y Imai, and T Osawa
December 1989, Clinical immunology and immunopathology,
Y Imai, and T Osawa
July 1971, Proceedings of the National Academy of Sciences of the United States of America,
Y Imai, and T Osawa
April 1980, Journal of immunology (Baltimore, Md. : 1950),
Y Imai, and T Osawa
January 1974, Journal of immunology (Baltimore, Md. : 1950),
Y Imai, and T Osawa
June 1979, Journal of immunology (Baltimore, Md. : 1950),
Y Imai, and T Osawa
August 1980, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!